Patient-reported satisfaction with symptom control during lanreotide autogel/depot (LAN) treatment for carcinoid syndrome (CS) in gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients: Symnet, a large multinational, cross-sectional, observational study

被引：0
|
作者：
Ruszniewski, Philippe B.
Caplin, Martyn E.
Valle, Juan W.
Bohas, Catherine Lombard
Maisonobe, Pascal
Atlan, Philippe
机构：
[1] Beaujon Hosp, Clichy, France
[2] Royal Free Hosp, Neuroendocrine Tumour Unit, London NW3 2QG, England
[3] Christie Hosp NHS Fdn Trust, European ENETS Ctr Excellence, Manchester, Lancs, England
[4] Hop Edouard Herriot, Lyon, France
[5] Ipsen, Boulougne Billancourt, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
273
引用
收藏
页数：1
相关论文
共 14 条
  • [1] SYMNET: A Study of Patient-Reported Outcomes (PROs) Associated with Lanreotide Autogel (LAN) for the Control of Carcinoid Syndrome (CS) Symptoms in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients (Pts)
    Ruszniewski, P.
    Caplin, M.
    Valle, L.
    Lombard-Bohas, D.
    Poston, G.
    Perros, P.
    Holubec, L.
    Delle Pave, G.
    Smith, D.
    Niccoli, P.
    Maisonobe, P.
    Atlan, P.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 274 - 274
  • [2] Patient-Reported Satisfaction with Diarrhea Control Associated with Lanreotide Autogel/Depot (LAN) Treatment for Carcinoid Syndrome (CS) Is High in Gastroenteropancreatic Neuroendocrine Tumor (NET) Patients
    Ruszniewski, Philippe
    Caplin, Marlyn E.
    Valle, Juan
    Lombard-Bohas, Catherine
    Poston, Graeme
    Perros, Petros
    Holubec, Lubo
    Delle Fave, Gianfranco
    Smith, Denis
    Niccoli, Patricia
    Maisonobe, Pascal
    Massien, Christine
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] Treatment Satisfaction, Symptom Control, and Quality of Life (QoL) With Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumor (NET) Patients With Carcinoid Syndrome (CS): Results From the SymNET Study
    Ruszniewski, Philippe
    Caplin, Martyn E.
    Valle, Juan W.
    Lombard-Bohas, Catherine
    Poston, Graeme
    Perros, Petros
    Holubec, Lubos
    Delle Fave, Gianfranco
    Smith, Denis
    Niccoli, Patricia
    Maisonobe, Pascal
    Gomez-Panzani, Edda
    PANCREAS, 2015, 44 (02) : 357 - 358
  • [4] Possible Predictors of Patient-Reported Satisfaction With Diarrhea Control Associated With Lanreotide Depot (LAN) Treatment for Carcinoid Syndrome (CS) in Gastroenteropancreatic Neuroendocrine Tumor (NET) Patients
    Ruszniewski, Philippe
    Caplin, Martyn
    Valle, Juan
    Lombard-Bohas, Catherine
    Poston, Graeme
    Perros, Petros
    Holubec, Lubos
    Delle Fave, Gianfranco
    Smith, Denis
    Niccoli, Patricia
    Maisonobe, Pascal
    Atlan, Philippe
    GASTROENTEROLOGY, 2014, 146 (05) : S212 - S212
  • [5] Lanreotide autogel/depot (LAN) treatment for carcinoid syndrome (CS) symptoms: Patient-reported outcomes (PROs) from the SYMNET study.
    Ruszniewski, Philippe B.
    Caplin, Martyn E.
    Valle, Juan W.
    Lombard-Bohas, Catherine
    Poston, Graeme John
    Perros, Petros
    Holubec, Lubos
    Delle Fave, Gianfranco
    Smith, Denis Michel
    Niccoli, Patricia
    Maisonobe, Pascal
    Atlan, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Treatment Satisfaction, Symptom Control and Quality of Life (QoL) with Lanreotide Autogel (LAN) in NET Patients with Carcinoid Syndrome (CS): Results from the SYMNET Study
    Ruszniewski, P.
    Caplin, M.
    Valle, J.
    Lombard-Bohas, C.
    Poston, G.
    Perros, P.
    Holubec, L.
    Delle Fave, G.
    Smith, D.
    Niccoli, P.
    Maisonobe, P.
    Atlan, P.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 126 - 126
  • [7] Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study
    Wolin, Edward M.
    Fisher, George A., Jr.
    Kunz, Pamela L.
    Liyanage, Nilani
    Lowenthal, Susan Pitman
    Mirakhur, Beloo
    Pommier, Rodney F.
    Shaheen, Montaser
    Vinik, Aaron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S468 - S468
  • [8] Efficacy of lanreotide autogel/depot (LAN) vs placebo (PBO) for symptomatic control of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT
    Wolin, E. M.
    Fisher, G. A.
    Kunz, P. L.
    Liyanage, N.
    Lowenthal, S. P.
    Mirakhur, B.
    Pommier, R. F.
    Shaheen, M.
    Vinik, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Longer term efficacy of lanreotide autogel/depot (LAN) for symptomatic treatment of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT open label study
    Fisher, G. A., Jr.
    Wolin, E.
    Kunz, P. L.
    Liyanage, N.
    Mirakhur, B.
    Lowenthal, S. Pitman
    Pommier, R. F.
    Shaheen, M.
    Vinik, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study
    Fisher, George A., Jr.
    Wolin, Edward M.
    Kunz, Pamela L.
    Liyanage, Nilani
    Mirakhur, Beloo
    Lowenthal, Susan Pitman
    Pommier, Rodney F.
    Shaheen, Montaser
    Vinik, Aaron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S457 - S458
12